Showing results (1221-1230 of 2,566) with videos related to
Sort By:
Pageof 257
Journal of Drug Targeting|April 7, 2021
Efficient antiglioblastoma therapy in mice through doxorubicin-loaded nanomicelles modified using a novel brain-targeted RVG-15 peptideMingfeng Han, Haoyue Xing, Liqing Chen, et al.Journal of Drug Targeting|October 12, 2012
Ocular delivery of cyclosporine A based on glyceryl monooleate/poloxamer 407 liquid crystalline nanoparticles: preparation, characterization, in vitro corneal penetration and ocular irritationYan Chen, Yi Lu, Yanqiang Zhong, et al.Journal of Drug Targeting|August 10, 2025
Research progress of microneedle drug delivery system in the treatment of autoimmune diseasesTiantian Wu, Xiaowei Li, Wei Wei, et al.Journal of Drug Targeting|August 10, 2025
Harnessing exosome-based drug delivery for the management of pregnancy-related disorders: a new frontier in obstetric therapeuticsFeihua Jin, Yaying Zhan, Shaomin Xu, et al.Journal of Drug Targeting|August 6, 2025
Multi-Omics approaches in gene therapy for vascular diseases: bridging genomics, transcriptomics, and epigeneticsJianxin Dong, Ming Sun, Yanmei Li, et al.Journal of Drug Targeting|August 10, 2025
Design, optimisation and in vivo evaluation of tazarotene loaded emulgel formulation for the treatment of acneAmit Pratap Singh, Sushil Kumar Kashaw, Vandana SoniJournal of Drug Targeting|August 6, 2025
Recent advancements in nanoparticle-based topical drug delivery systems for psoriasis treatmentRitwik Mitra, Dinesh Kumar Sharma, Arnab Ghosh, et al.Journal of Drug Targeting|August 4, 2025
Ofirnoflast: a first-in-class NEK7-targeted inhibitor of the NLRP3 inflammasomeAlexis Mollard, Devan Bursey, William Burnett, et al.Journal of Drug Targeting|July 16, 2025
Bipartite 5-fluorouracil and lepidine-based nanoemulsion gel: in vitro and dermatokinetic evaluationZeba Usmani, Samreen Jahan, Zakiya Usmani, et al.Journal of Drug Targeting|July 14, 2025
Dual AMPK activation and TXNIP suppression underlie the superior anti-diabetic action of rosiglitazone-metformin co-crystal (RZM): evidence from preclinical modelsLeping Ruan, Yi Song, Gang Wang, et al.Pageof 257